… Despite the similar overall toxicity profile, CET and PANI … toxicities associated with each
single anti-EGFR agent and eventually find possible differences in the incidence of skin toxicities…

… Cutaneous toxicity in cetuximab-treated patients is summarized in Table 3. We report the
acne-like rash to be the most frequent cutaneous side effect of cetuximab therapy experienced …

… toxicity with cetuximab and radiotherapy, comparing it with a matched cisplatin group. The
cetuximab group experienced significantly more toxicity – … This finding of enhanced toxicity is …

… The most common toxicity associated with cetuximab treatment … Due to the additional toxicity
associated with cisplatin given … cetuximab does not significantly increase the acute toxicities …

… had squamous cell cancer. Fourteen of 60 patients (23%) had Grade 3 dermatologic toxicity
… Three patients had Grade 3/4 cetuximab hypersensitivity reactions and were not assessable …

… Possible cetuximab effects on healthy tissues responsible for skin toxicity (C) Acquired resistance
to cetuximab… to cetuximab. (D) Combined treatment with ICI. Possible synergy between …

… that the reaction was probably related to cetuximab. Severe complications of ILD have been
… neck cancer receiving cetuximab in clinical trials resulting in 1 death from the colon cancer …

… Cetuximab was demonstrated by clinical trials to improve response rate and survival of …
colorectal cancer or carcinoma of the head and neck. Appropriate management of skin toxicity …

… Our early experience with cetuximab/RT has demonstrated a higher rate of toxicity compared
with the recently reported randomised trial, resulting in low treatment compliance and …

… Purpose: The aim of this study was to investigate the efficacy of the combination of
irinotecan/cetuximab and to plan related skin toxicity management with an oncologic/dermatologic …